Please login to the form below
Prescription Digital Therapeutics
This page shows the latest Prescription Digital Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
Pear Therapeutics is a pioneer of so-called digital therapeutics, having gained the first ever such approval from the FDA in 2017, for its treatment for patients with Substance Use Disorder ... Its Prescription Digital Therapeutics (PDTs) are app-based
Latest news
-
FDA clears Sandoz and Pear’s Opioid Use Disorder app
validated software-based therapeutics, known as Prescription Digital Therapeutics (PDT). ... Richard Francis, CEO, Sandoz. "New digital therapeutics such as reSET-O also have the potential to fundamentally change how patients interact with their
-
Novartis plans digital therapeutics for schizophrenia and MS
Novartis shares our vision for prescription digital therapeutics that work alongside drugs to deliver superior patient outcomes. ... We believe this collaboration further supports the clinical viability of prescription digital therapeutics as an emerging
-
FDA approves first substance use mobile medical application
Corey McCann, Pear’s president and CEO, said: “This is a defining moment for digital therapeutics and for patients with substance use disorder. ... We believe that prescription digital therapeutics hold promise in improving patient outcomes across a
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Impetus Digital Fireside Chat with with Jon Sockell, Co-Founder/COO of Limbix
Limbix Spark is the first prescription digital therapeutic designed to support adolescents with depression. ... See how Limbix is paving the way for prescription digital therapeutics and learn from their trials, tribulations, successes, and vision for
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Senior Account Manager
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Medical Editor
-
Competitive
- PHE study finds people who have had COVID-19 can still transmit the virus
- Sinovac’s COVID-19 vaccine appears safe in older adults
- PHE study finds people who have had COVID-19 can still transmit the virus
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- New study identifies drugs that are safe to use in COVID-19 treatment
- AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
- Onyx Health Celebrates Its 10th Anniversary with Five New Hires
- Merck’s appeal to restore hepatitis C patent verdict against Gilead fails
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Trial combining British and Russian COVID-19 vaccines could begin in February
- New Oxford research institute established to tackle antimicrobial resistance
- EU proposes vaccine-sharing mechanism with low-income countries
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- Recent years have seen a significant shift in drug development to specialty areas...
- 2020 - a year to remember or forget?
- 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
- The search for effective drug treatments for COVID-19
- PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
Quick links
Infographics
